|
|
|
|
|
|
| |
|
Newsletter Sponsor
|
|
Formulations for Poorly Water-Soluble Molecules
Ascendia Pharma specializes in formulations for poorly water-soluble molecules and other challenging development projects using a suite of technologies that include nano-emulsions, amorphous solid dispersions, nano-particles and oral controlled release. Ascendia offers cGMP manufacturing for Phase I clinical trials, so formulation optimization can quickly transition to clinical proof-of-concept. Dosage forms for oral, topical or injectable delivery can be developed.
 |
|
|
|
|
|
|
|
|
 |
Featured Articles |
 |
|
| |
Microbiology Roundtable
Charles River Laboratories, Senior Product Manager, Accugenix: Besides the obvious answer of COVID-19 vaccine production, availability, and safety, we...
read more » |
 |
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
| |
|
Events |
|
|
| |
|
|
|
|
Excipient World 2021
National Harbor, MD – 09/27/2021
Excipient World is the leading education, networking and sourcing resource for the $6+ billion and growing global excipient market. It’s the ONLY U.S....
event details » |
|
|
|
 |
|
|
